Dr Hatahet is Syrian registered pharmacist. He completed his Bachelor of pharmacy degree in Syria from Arab International University in 2013. Following receiving the prestigious Erasmus Mundus Avempace 2 Award from the EU commission, He started his PhD in the institute Charles Gerhardt (ICGM) / University of Montpellier, France. Within the research team of advanced materials for health and catalysis, his PhD research project focused on developing novel lipid based nanoformulations and Nanocrystals for the delivery of antioxidants through the skin. In 2016, Dr Hatahet joined University of Rennes1, School of Pharmacy as a Research and teaching Fellow focusing on Polymeric nanoparticles for delivery of inorganic photosensitizing agents for the theranostic management of ovarian cancer. In May 2018, Dr Hatahet joined Queen’s University Belfast School of Pharmacy as a lecturer in pharmaceutical sciences.

Dr Hatahet research focuses on developing novel nanomaterials for delivering a broad range of therapeutic agents, and to fabricate multifunctional nanoparticles to target cancer and other diseases. His long-term research career is to facilitate the translation of nanoparticle-based systems from the lab to the clinic.

Dr Hatahet teaches in QUB main campus in Belfast and in China medical university-Queen’s university Belfast joint college (CQC) in Shenyang, China. He is teaching in drug delivery and drug analysis modules in level 2 and 3 where he coordinates drug delivery modules in level 3 BSc program of pharmaceutical sciences (PS) and pharmaceutical biotechnology (PB) programs in China. Dr Hatahet works on pedagogical research to improve student engagement and learning through different blended learning approaches in CQC. In parallel to other administrative duties, He is the advisor of studies for the BSc PS program in China.